浙江新光药业股份有限公司 关于召开 2025 年第一次临时股东大会通知的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 浙江新光药业股份有限公司（以下简称"公司"）第五届董事会第五次会 议审议通过了《关于提请召开公司 2025 年第一次临时股东大会的议案》，决定 于 2025 年 9 月 12 日召开公司 2025 年第一次临时股东大会，审议董事会、监事 会提交的相关议案。现将本次股东大会的有关事项通知如下： 证券代码：300519 证券简称：新光药业 公告编号：2025-025 4、会议召开的日期、时间 （1）现场会议召开时间：2025 年 9 月 12 日（星期五）下午 14:00； （2）网络投票时间：2025 年 9 月 12 日，其中： ①通过深圳证券交易所（以下简称"深交所"）交易系统进行网络投票的 时间为：2025 年 9 月 12 日 9:15—9:25，9:30-11:30，13:00-15:00； ②通过深交所互联网系统投票的具体时间为：2025 年 9 月 12 日 9:15— 15:00 期间的任意时间。 5、会议的召开方式：本次 ...

Group 1 - The core point of the article highlights that Zhejiang Xinguang Pharmaceutical Co., Ltd. has experienced a decline in stock price over four consecutive trading days, with a cumulative drop of -4.41% [1] - Xinguang Pharmaceutical is described as a modern pharmaceutical enterprise that integrates production and operation, located in Shengzhou, Zhejiang Province [1] - The financial report indicates that Jinyuan Shun'an Fund's Jinyuan Shun'an Yuanqi Flexible Allocation Mixed Fund has entered the top ten shareholders of Xinguang Pharmaceutical, marking its new entry in the first quarter of this year [1] Group 2 - The Jinyuan Shun'an Yuanqi Flexible Allocation Mixed Fund has achieved a year-to-date return of 30.26%, ranking 342 out of a total of 2282 similar funds [1] - The fund manager, Miao Weibin, has a background in economics from Fudan University and has held various positions in asset management prior to joining Jinyuan Shun'an Fund Management Co., Ltd. in October 2016 [3][4] - Miao Weibin has managed the Jinyuan Shun'an Yuanqi Flexible Allocation Mixed Fund since November 14, 2017, achieving a return of 508.33% over his tenure [4]

金融界消息 截至2025年8月12日收盘，新光药业（300519）报收于17.32元，下跌1.81%，换手率 6.11%，成交量6.97万手，成交金额1.21亿元。 资金流向方面，今日主力资金净流出1636.72万元，占比成交额13.5%。其中，超大单净流出289.51万 元、占成交额2.39%，大单净流出1347.22万元、占成交额11.12%，中单净流出流出472.31万元、占成交 额3.9%，小单净流入2109.04万元、占成交额17.4%。 新光药业最新一期业绩显示，截至2025一季报，公司营业总收入9325.01万元、同比减少7.26%，归属净 利润2454.18万元，同比增长7.50%，扣非净利润2336.65万元，同比增长9.49%，流动比率13.066、速动 比率12.251、资产负债率7.46%。 天眼查商业履历信息显示，浙江新光药业股份有限公司，成立于1998年，位于绍兴市，是一家以从事医 药制造业为主的企业。企业注册资本16000万人民币，实缴资本16000万人民币。公司法定代表人为王岳 钧。 通过天眼查大数据分析，浙江新光药业股份有限公司共对外投资了4家企业，参与招投标项目26次，知 ...

格隆汇8月5日｜A股开盘，上证指数涨0.15%，深证成指涨0.34%，创业板指涨0.65%。盘面上，消费电 子概念盘初活跃，易德龙(603380)、福日电子(600203)涨停；"两船合并"新进展，将于8月13日起双双停 牌，中国船舶(600150)涨超3%，中国重工(601989)涨超2%；部分影视院线股回调，幸福蓝海(300528)跌 超3%；中药板块盘初走低，奇正藏药(002287)、新光药业(300519)跌超5%。(格隆汇) (责任编辑：宋政 HN002) 【免责声明】本文仅代表作者本人观点，与和讯网无关。和讯网站对文中陈述、观点判断保持中立，不对所包含内容 的准确性、可靠性或完整性提供任何明示或暗示的保证。请读者仅作参考，并请自行承担全部责任。邮箱： news_center@staff.hexun.com ...

Group 1 - The latest stock price of Xinguang Pharmaceutical is 20.05 yuan, an increase of 0.25 yuan from the previous trading day [1] - The stock opened at 18.86 yuan, reached a high of 20.28 yuan, and a low of 18.15 yuan, with an overall fluctuation of 10.76% throughout the day [1] - The trading volume was 260,458 hands, with a total transaction amount of 491 million yuan [1] Group 2 - Xinguang Pharmaceutical operates in the pharmaceutical manufacturing industry, specifically in the traditional Chinese medicine production sector [1] - The company is primarily engaged in the research, development, production, and sales of traditional Chinese medicine, chemical drug formulations, and raw materials [1] - Its product range covers multiple therapeutic areas, including cardiovascular, digestive, and respiratory systems [1] Group 3 - On August 4, the stock experienced a rapid rebound during the morning trading session, with a rise of over 2% within 5 minutes [1] - As of 9:37 AM, the stock price was reported at 18.95 yuan, with a transaction amount reaching 105 million yuan [1] - In terms of capital flow, there was a net outflow of 4.5732 million yuan from the main funds on that day, accounting for 0.2% of the circulating market value [1] - Over the past five trading days, the cumulative net inflow of main funds was 22.5547 million yuan, representing 0.99% of the circulating market value [1]

(责任编辑：宋政 HN002) 格隆汇8月1日｜A股市场中药股逆势上涨，其中，生物谷涨近25%，维康药业20CM涨停，新光药业 (300519)涨13%，大唐药业涨近11%，天目药业(600671)、新天药业(002873)、太龙药业(600222)、奇正 藏药(002287)、贵州百灵(002424)10CM涨停，众生药业(002317)涨超8%，亚宝药业(600351)、沃华医药 (002107)涨超6%。 | 代码 | 名称 | 涨幅% ↓ | 总市值 | 年初至今涨幅%。 | | --- | --- | --- | --- | --- | | 833266 | 生物谷 | 24.91 | 17.60亿 | 51.12 | | 300878 | 维康药业 | 20.00 | 37.10亿 | 71.51 | | 300519 | 新光药业 | 13.04 | 31.76亿 | 52.71 | | 836433 | 大唐药业 | 10.76 | 22.14亿 | 42.65 | | 600671 | 天目药业 | 10.03 | 18.71亿 | 74.94 | | 002873 | 新天药业 | 10. ...

MACD金叉信号形成，这些股涨势不错！ 格隆汇8月1日｜A股市场中药股逆势上涨，其中，生物谷（维权）涨近25%，维康药业（维权）20CM 涨停，新光药业涨13%，大唐药业涨近11%，天目药业、新天药业、太龙药业、奇正藏药、贵州百灵 （维权）10CM涨停，众生药业涨超8%，亚宝药业、沃华医药（维权）涨超6%。 | 代码 | 名称 | 涨幅% ↓ | 总市值 | 年初至今涨幅% | | --- | --- | --- | --- | --- | | 833266 | 生物谷 | 24.91 | 17.60亿 | 51.12 | | 300878 | 维康药业 | 20.00 | 37.10亿 | 71.51 | | 300519 | 新光药业 | 13.04 | 31.76 乙 | 52.71 | | 836433 | 大唐药业 | 10.76 | 22.14亿 | 42.65 | | 600671 | 天目药业 | 10.03 | 18.71亿 | 74.94 | | 002873 | 新天药业 | 10.03 | 29.19亿 | 27.68 | | 600222 | 太龙药业 | 10.00 | 39.14 ...

（文章来源：每日经济新闻） 每经AI快讯，8月1日，午后中药板块持续逆势拉升，天目药业、华森制药涨停，生物谷一度触及30%涨 停，新光药业、大唐药业涨超10%，亚宝药业、沃华医药、陇神戎发、粤万年青等跟涨。 ...

Group 1 - The A-share traditional Chinese medicine sector is experiencing a significant upward trend, with companies like Tianmu Pharmaceutical and Huasen Pharmaceutical hitting the daily limit increase [1] - Biotech Valley reached a peak of 30cm limit increase, indicating strong market interest and investor confidence [1] - Other companies such as New Light Pharmaceutical and Datang Pharmaceutical saw increases of over 10%, reflecting a broader positive movement in the sector [1] Group 2 - Additional companies including Yabao Pharmaceutical, Wohua Pharmaceutical, Longshen Rongfa, and Guangdong Wannianqing also showed gains, contributing to the overall bullish sentiment in the traditional Chinese medicine market [1]

A股辅助生殖板块持续走强，福元医药盘中创历史新高，共同药业、汉商集团、利德曼涨停，安科生物 涨超15%，广生堂涨超10%，新光药业、达嘉维康、贝因美、星昊医药、贝瑞基因跟涨。 ...